Camber Capital Management Lp Top Holdings and 13F Report (2025) About Camber Capital Management LpInvestment ActivityCamber Capital Management Lp has $1.07 billion in total holdings as of June 30, 2025.Camber Capital Management Lp owns shares of 25 different stocks, but just 11 companies or ETFs make up 80% of its holdings.Approximately 12.64% of the portfolio was purchased this quarter.About 174.72% of the portfolio was sold this quarter.This quarter, Camber Capital Management Lp has purchased 31 new stocks and bought additional shares in 1 stock.Camber Capital Management Lp sold shares of 17 stocks and completely divested from 10 stocks this quarter.Largest Holdings SPDR S&P 500 ETF Trust $308,925,000Zimmer Biomet $91,210,000Baxter International $86,298,000Humana $73,344,000CVS Health $72,429,000 Largest New Holdings this Quarter G4705A100 - Icon $43,635,000 Holding58933Y105 - Merck & Co., Inc. $39,580,000 Holding91324P102 - UnitedHealth Group $31,197,000 Holding03753U106 - Apellis Pharmaceuticals $14,713,500 Holding Largest Purchases this Quarter Icon 300,000 shares (about $43.64M)Merck & Co., Inc. 500,000 shares (about $39.58M)UnitedHealth Group 100,000 shares (about $31.20M)Apellis Pharmaceuticals 850,000 shares (about $14.71M)BioMarin Pharmaceutical 100,000 shares (about $5.50M) Largest Sales this Quarter SPDR S&P 500 ETF Trust 1,000,000 shares (about $617.85M)Pfizer 7,800,000 shares (about $189.07M)Zimmer Biomet 1,250,000 shares (about $114.01M)Humana 425,000 shares (about $103.90M)Baxter International 2,900,000 shares (about $87.81M) Sector Allocation Over TimeMap of 500 Largest Holdings ofCamber Capital Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorSPYSPDR S&P 500 ETF Trust$308,925,000$617,850,000 ▼-66.7%500,00029.0%FinanceZBHZimmer Biomet$91,210,000$114,012,500 ▼-55.6%1,000,0008.6%MedicalBAXBaxter International$86,298,000$87,812,000 ▼-50.4%2,850,0008.1%MedicalHUMHumana$73,344,000$103,904,000 ▼-58.6%300,0006.9%MedicalCVSCVS Health$72,429,000$82,776,000 ▼-53.3%1,050,0006.8%MedicalGMEDGlobus Medical$47,216,000$26,559,000 ▼-36.0%800,0004.4%MedicalICLRIcon$43,635,000$43,635,000 ▲New Holding300,0004.1%MedicalASNDAscendis Pharma A/S$43,150,000$17,260,000 ▼-28.6%250,0004.1%MedicalMRKMerck & Co., Inc.$39,580,000$39,580,000 ▲New Holding500,0003.7%MedicalGSKGSK$38,400,0000.0%1,000,0003.6%MedicalPFEPfizer$36,360,000$189,072,000 ▼-83.9%1,500,0003.4%MedicalBMRNBioMarin Pharmaceutical$32,982,000$5,497,000 ▲20.0%600,0003.1%MedicalUNHUnitedHealth Group$31,197,000$31,197,000 ▲New Holding100,0002.9%MedicalVTRSViatris$24,557,500$42,417,500 ▼-63.3%2,750,0002.3%MedicalBKDBrookdale Senior Living$14,964,000$28,536,000 ▼-65.6%2,150,0001.4%MedicalZIMVZimVie$14,960,000$2,664,750 ▼-15.1%1,600,0001.4%MedicalAPLSApellis Pharmaceuticals$14,713,500$14,713,500 ▲New Holding850,0001.4%MedicalMYGNMyriad Genetics$10,620,000$1,858,500 ▼-14.9%2,000,0001.0%MedicalEVHEvolent Health$9,571,000$24,209,000 ▼-71.7%850,0000.9%Computer and TechnologyCONCENTRA GROUP HOLDINGS PAR$8,228,000$24,684,000 ▼-75.0%400,0000.8%COMMON STOCKINGNInogen$6,854,2500.0%975,0000.6%MedicalDNLIDenali Therapeutics$5,596,000$11,891,500 ▼-68.0%400,0000.5%MedicalTBPHTheravance Biopharma$4,963,500$6,066,500 ▼-55.0%450,0000.5%MedicalANABAnaptysBio$2,775,000$13,875,000 ▼-83.3%125,0000.3%MedicalOSUROraSure Technologies$2,700,0000.0%900,0000.3%MedicalXBISPDR S&P Biotech ETF$0$162,200,000 ▼-100.0%00.0%ETFPTCTPTC Therapeutics$0$76,440,000 ▼-100.0%00.0%MedicalCICigna Group$0$65,800,000 ▼-100.0%00.0%MedicalQIAGEN NV$0$56,210,000 ▼-100.0%00.0%COM SHSSRPTSarepta Therapeutics$0$51,056,000 ▼-100.0%00.0%MedicalIONSIonis Pharmaceuticals$0$21,873,250 ▼-100.0%00.0%MedicalMLTXMoonLake Immunotherapeutics$0$17,229,870 ▼-100.0%00.0%MedicalTXG10x Genomics$0$8,730,000 ▼-100.0%00.0%MedicalGPCRStructure Therapeutics$0$5,193,000 ▼-100.0%00.0%MedicalGMABGenmab A/S$0$979,000 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access